Karen Lindorff-Larsen

Dr. Karen Lindorff-Larsen


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2014 in Nutrients
Verified
Journal Article
Open access
PDF file
LSLone Schmidt Soerensen
Lone Schmidt Soerensen
OTOle Thorlacius-Ussing
Ole Thorlacius-Ussing
HRHenrik H. Rasmussen
Henrik H. Rasmussen
SLSøren Lundbye-Christensen
Søren Lundbye-Christensen
PCPhilip Calder
Philip Calder
ESErik Berg Schmidt
Erik Berg Schmidt
Omega-3 fatty acids (n-3 FA) may have beneficial clinical and immune-modulating effects in surgical patients. In a randomized, double-blind, prospective, placebo-controlled trial, 148 patients referred for elective colorectal cancer surgery received an n-3 FA-enriched oral nutritional supplement (ONS) providing 2.0 g of eicosapentaenoic acid (EPA) and 1.0 g of docosahexaenoic acid (DHA) per day or a standard ONS for seven days before surgery. On the day of operation, there was a significant increase in the production of leukotriene B5 (LTB5) (p < 0.01) and 5-hydroxyeicosapentaenoic acid (5-HEPE) (p < 0.01), a significant decrease in the production of leukotriene B4 (LTB4) (p < 0.01) and a trend for a decrease in the production of 5-hydroxyeicosatetraenoic acid (5-HETE) (p < 0.1) from stimulated neutrophils in the active group compared with controls. There was no association between LTB4 values and postoperative complications. In conclusion, oral n-3 FA exerts anti-inflammatory effects in surgical patients, without reducing the risk of postoperative complications.

1 April 2015 in Clinical Nutrition
Verified
Journal Article
Closed access
MHM. Holst
M. Holst
TBT. Beermann
T. Beermann
MMM.N. Mortensen
M.N. Mortensen
LSL.B. Skadhauge
L.B. Skadhauge
KLKaren Lindorff-Larsen
Karen Lindorff-Larsen
HRH.H. Rasmussen
H.H. Rasmussen